Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
To be a CooperCompanies shareholder, you need to believe that premium daily lenses and myopia management can support resilient earnings and cash generation, even if the broader contact lens market grows more slowly. The latest guidance raise supports that thesis and, in the near term, reinforces the main catalyst around ramping MyDay and MiSight, while doing little to reduce the key risk that weaker category growth could still cap revenue and margin expansion.
Among recent announcements, the launch of MyDay MiSight 1-day lenses in the UK and parts of Europe ties directly into the current quarter’s story, since it extends the premium, higher margin myopia management portfolio that management highlights as a quality growth driver. How effectively this rollout converts fitting and trial activity into recurring orders will be central to whether the upgraded earnings and free cash flow guidance proves sustainable.
Yet beneath the raised guidance, investors should be aware of the risk that a slower growing global contact lens market could still...
Read the full narrative on Cooper Companies (it's free!)
Cooper Companies' narrative projects $4.9 billion revenue and $810.1 million earnings by 2029. This requires 5.5% yearly revenue growth and around a $408.7 million earnings increase from $401.4 million today.
Uncover how Cooper Companies' forecasts yield a $91.80 fair value, a 32% upside to its current price.
Four members of the Simply Wall St Community currently see fair value for CooperCompanies between US$43.49 and US$91.80, reflecting very different expectations. When you set those views against the importance of MyDay and MiSight execution to the company’s earnings profile, it becomes clear why considering multiple perspectives on the growth and risk outlook matters.
Explore 4 other fair value estimates on Cooper Companies - why the stock might be worth 38% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English